Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

With COVID cases on the rise in many countries, the race to find an effective vaccine is becoming a more pressing concern ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

Flu season approaches and there's a new COVID variant. The time to act is now, or soon, according to the two largest local ...

Even as the Covid wave in Florida continues, Gov. Ron DeSantis’ administration is once again advising against the mRNA ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

In comparison, at its current levels of around $195, AbbVie stock trades at 18x expected 2024 earnings of $10.88 per share. This compares with the 12x average P/E multiple for ABBV seen over the last ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

A summer wave of cases locally and across the country may be on the decline and a vaccine targeting the latest variants is ...